Report provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Reperfusion Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Reperfusion Injury.

1. Reperfusion Injury - Pipeline Review, H1 2013
Global Markets Direct’s, 'Reperfusion Injury - Pipeline Review, H1 2013', provides an overview of the
indication’s therapeutic pipeline. This report provides information on the therapeutic development for
Reperfusion Injury, complete with latest updates, and special features on late-stage and discontinued projects.
It also reviews key players involved in the therapeutic development for Reperfusion Injury.
Reperfusion Injury - Pipeline Review, Half Year is built using data and information sourced from Global
Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of
data for the indicated disease.
Scope
A snapshot of the global therapeutic scenario for Reperfusion Injury. A review of the Reperfusion Injury
products under development by companies and universities/research institutes based on information derived
from company and industry-specific sources. Coverage of products based on various stages of development
ranging from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and
combined therapeutics. Coverage of the Reperfusion Injury pipeline on the basis of route of administration and
molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products.
Reasons to buy
Identify and understand important and diverse types of therapeutics under development for Reperfusion
Injury. Identify emerging players with potentially strong product portfolio and design effective
counter-strategies to gain competitive advantage. Plan mergers and acquisitions effectively by identifying
players of the most promising pipeline. Devise corrective measures for pipeline projects by understanding
Reperfusion Injury pipeline depth and focus of Indication therapeutics. Develop and design in-licensing and
out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and
expand business potential and scope. Modify the therapeutic portfolio by identifying discontinued projects and
understanding the factors that drove them from pipeline.
table Of Content
introduction
global Markets Direct Report Coverage
reperfusion Injury Overview
therapeutics Development
an Overview Of Pipeline Products For Reperfusion Injury
reperfusion Injury Therapeutics Under Development By Companies
reperfusion Injury Therapeutics Under Investigation By Universities/institutes
late Stage Products
Reperfusion Injury - Pipeline Review, H1 2013

2. comparative Analysis
mid Clinical Stage Products
comparative Analysis
early Clinical Stage Products
comparative Analysis
discovery And Pre-clinical Stage Products
comparative Analysis
reperfusion Injury Therapeutics – Products Under Development By Companies
reperfusion Injury Therapeutics – Products Under Investigation By Universities/institutes
companies Involved In Reperfusion Injury Therapeutics Development
pharming Group N.v.
biolinerx, Ltd.
teva Pharmaceutical Industries Limited
proteo, Inc.
neurovive Pharmaceutical Ab
scynexis, Inc.
prolong Pharmaceuticals
trophos Sa
curatis Pharma Gmbh
alligator Bioscience Ab
opsona Therapeutics Ltd.
pledpharma Ab
omeros Corporation
bolder Biotechnology, Inc.
max Planck Innovation Gmbh
adienne Pharma & Biotech
dr. Franz Kohler Chemie Gmbh
genextra S.p.a.
apeptico Forschung Und Entwicklung Gmbh
tolerotech Inc.
mt Cook Pharma. Inc.
ischemix
reperfusion Injury – Therapeutics Assessment
assessment By Monotherapy Products
assessment By Route Of Administration
assessment By Molecule Type
drug Profiles
pmx-53 - Drug Profile
cgen-855a - Drug Profile
cgen-855b - Drug Profile
elafin - Drug Profile
tro-40303 - Drug Profile
adc-1004 - Drug Profile
Reperfusion Injury - Pipeline Review, H1 2013

3. oms-721 - Drug Profile
cmx-2043 - Drug Profile
mtp-131 - Drug Profile
ciclomulsion - Drug Profile
evasin-3 - Drug Profile
conestat Alfa - Drug Profile
bbt-045 - Drug Profile
eu-c-002 - Drug Profile
ap-301 - Drug Profile
opn-305 - Drug Profile
mcp-205 - Drug Profile
sanguinate - Drug Profile
custodiol-n - Drug Profile
sodium Nitrite - Drug Profile
curaglutide - Drug Profile
cmx-272xx - Drug Profile
adam17 Inhibitor - Drug Profile
edp-09 - Drug Profile
apt-102 - Drug Profile
cyclophilin Inhibitory Compounds - Drug Profile
drug Targeting Neuronal Nitric Oxide Synthase - Drug Profile
nkt Ii Cell Modulator - Drug Profile
ara-290 - Drug Profile
xgp-610 - Drug Profile
pnu-282987 - Drug Profile
alpha-1-antitrypsin - Drug Profile
pp-099 - Drug Profile
type 5 Adenylyl Cyclase Inhibitors - Drug Profile
beta 2-glycoprotein I Peptides - Drug Profile
drug For Reperfusion Injury - Drug Profile
caffeic Acid Phenethyl Ester - Drug Profile
mptp Inhibitors - Drug Profile
drug For Ischemia/reperfusion Injury - Drug Profile
siischemia - Drug Profile
compound 9 - Drug Profile
pin-201601 - Drug Profile
glutathione Peroxidase Mimetic Compounds - Drug Profile
ixac - Drug Profile
na/k-atpase-specific Src Modulator - Drug Profile
pviia - Drug Profile
riiik - Drug Profile
reperfusion Injury Therapeutics – Drug Profile Updates
reperfusion Injury Therapeutics – Discontinued Products
Reperfusion Injury - Pipeline Review, H1 2013

4. reperfusion Injury Therapeutics - Dormant Products
reperfusion Injury – Product Development Milestones
featured News & Press Releases
appendix
methodology
coverage
secondary Research
primary Research
expert Panel Validation
contact Us
disclaimer
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Reperfusion Injury - Pipeline Review, H1 2013